[1] |
ZHANG Ying, JING Lijuan, LI Li.
Relationship between the expression of miR-138 in peripheral blood mononuclear cells of hepatitis B virus proliferation in carriers
[J]. Laboratory Medicine, 2023, 38(6): 559-562.
|
[2] |
GU Yi, WANG Rui, DENG Jie, YANG Yijing, ZHOU Wangke, CHEN Yunuo, CHEN Xiaosong, SHEN Wei, ZHOU Jingyi.
Differential analysis and prognostic diagnostic value of inflammatory biomarkers in liver transplantation in patients with severe hepatitis and cirrhosis
[J]. Laboratory Medicine, 2023, 38(11): 1044-1051.
|
[3] |
LIU Yang, GENG Kunjing, LI Hongjiang, SHI Haoxi, CHEN Sisi.
Relationship of 25(OH)D3 and liver inflammatory stage with the efficacy of antiviral therapy
[J]. Laboratory Medicine, 2022, 37(7): 628-631.
|
[4] |
WU Sujun, JI Hengtao, PENG Mengle.
Clinical values of IL-18,IL-37,NLRP3 and NK/DC ratio in hepatitis B-related liver cirrhosis
[J]. Laboratory Medicine, 2022, 37(6): 518-523.
|
[5] |
MA Yanting, SU Xi, HUANG Fei, WANG Mengxian, SHEN Minna, ZHANG Chunyan, WANG Beili, PAN Baishen, GUO Wei.
Clinical role of HBV RNA detection in chronic hepatitis B
[J]. Laboratory Medicine, 2022, 37(1): 72-77.
|
[6] |
LI Caidong, ZHANG Xuqiang, LEI Zhiping, CHEN Qiaoli, CHEN Lu, TIAN Pengfei, DUAN Zhengjun.
Clinical values of IL-1β,IL-6 and TNF-α in different clinical courses of chronic HBV infection
[J]. Laboratory Medicine, 2021, 36(8): 790-794.
|
[7] |
LIU Tingting, LIN Yuting, Mila , LI Xiaoqin.
Correlation between serum IL-33 level and its gene polymorphism and the clinical outcome of HBV infection
[J]. Laboratory Medicine, 2021, 36(11): 1101-1105.
|
[8] |
SONG Hui, YANG Lan, XU Limin, SHEN Zhenhua, LIU Qianqian, LIU Xinghui.
Influence and mechanism of hepatitis B virus on the expression of HOXA10
[J]. Laboratory Medicine, 2021, 36(11): 1172-1176.
|
[9] |
YUAN Yongming, ZHANG Xiaoying, GU Chao, ZHANG Jue, SUN Xuehua.
Analysis of hepatitis B virus S protein mutation in chronic hepatitis B and cirrhosis patients
[J]. Laboratory Medicine, 2020, 35(5): 428-433.
|
[10] |
GUO Ping, ZHUANG Lihua, CHEN Liting, WANG Jianbiao, WU Jianfeng.
Roles of MCV,RDW and SAA in the progression of chronic hepatitis B
[J]. Laboratory Medicine, 2020, 35(11): 1153-1157.
|
[11] |
LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun.
Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg
[J]. Laboratory Medicine, 2020, 35(10): 1056-1061.
|
[12] |
WANG Yingzhi, LIU Hua, WANG Wenjuan, GAO Feng, YANG Cuixia.
Roles of serum microRNA-122 and microRNA-155 in patients with chronic hepatitis B
[J]. Laboratory Medicine, 2019, 34(8): 691-695.
|
[13] |
YU Xiaochun, HU Xujiao, ZHANG Jiaqing, GUO Leilei.
Roles of HA,Ⅳ-C,APRI and Fib-4 in the diagnosis of hepatitis B-related liver fibrosis
[J]. Laboratory Medicine, 2019, 34(6): 539-542.
|
[14] |
JIANG Lingli, XIAO Yanqun, WANG Xueliang, BAO Yun, YANG Yixiao, WANG Hualiang.
Development and application of external quality assessment research material for YMDD mutation detection of hepatitis B virus
[J]. Laboratory Medicine, 2019, 34(2): 176-179.
|
[15] |
GAO Wanqin, ZHANG Qin, ZHU Lin, WU Bin, HE Wentao, ZHANG Tinglu, ZHAO Changxin.
Analysis of genotyping and 6 nucleosides' resistance of HBV in patients with chronic hepatitis B
[J]. Laboratory Medicine, 2019, 34(11): 994-997.
|